Trial Profile
Study of infliximab for cardiac sarcoidosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jul 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Sarcoidosis
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society